WBIO — WPD Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.57m
- CA$0.89m
Annual cashflow statement for WPD Pharmaceuticals, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 January 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.779 | -7.52 | -5.62 | 3.86 | -0.08 |
| Depreciation | |||||
| Non-Cash Items | -0.009 | 4.79 | 0.454 | -4.28 | -0.188 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.017 | 0.955 | 3.39 | -3.03 | 0.057 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.772 | -1.38 | -1.49 | -3.43 | -0.205 |
| Capital Expenditures | — | -0.645 | -0.071 | -0.036 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.78 | 0 | 0 | -0.203 | 0 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.78 | -0.645 | -0.071 | -0.239 | 0 |
| Financing Cash Flow Items | 2.75 | — | 0 | 0.503 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.16 | 1.02 | 0.992 | 1.23 | 0.267 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.606 | -1.08 | -0.16 | -1.68 | 0.062 |